The 2021 International Clinical Researcher of the Year virtual finals days took place over the 15th and 16th of June.
News
US approves Pradaxa as oral blood thinning med for children
First oral blood thinning drug approved for paediatric patients in the US
ABPI launches new Patient Advisory Council
The council will be comprised of senior leaders from the patient charity sector
EU green lights AZ, MSD’s rare disease therapy Koselugo
Drug approved to treat children with neurofibromatosis type 1 and plexiform neurofibromas
NHS England announces extra funding for young people’s mental health services
An extra £40m will go toward enhancing mental health services for children and young people
US approval for OTC use of Bayer’s Astepro
Approval makes Astepro the first and only OTC steroid free antihistamine nasal spray available in the US
Novartis’ radioligand therapy granted US Breakthrough Therapy Designation
Lu-PSMA-617 is a potential treatment for metastatic castration-resistant prostate cancer
Zolgensma shows promise in presymptomatic SMA patients
Children treated with gene therapy prior to symptom presentation achieved motor milestones not seen in the natural history of SMA
EC approves Sanofi’s Aubagio for paediatric MS patients
Aubagio has been authorised for the treatment of paediatric patients aged ten to 17 years living with RRMS
Novartis’ Cosentyx wins NICE backing for non-radiographic axial spondyloarthritis
Axial spondyloarthritis affects approximately one in 200 people in the UK
Pfizer’s JAK inhibitor Xeljanz shows benefit in COVID-19 pneumonia
Xeljanz reduced the incidence of death or respiratory failure compared to placebo in hospitalised patients
Researchers identify new drug class with potential in BRCA-mutated tumours
POLQ inhibitors could be used to kill PARP inhibitor-resistant cancer cells
Gov’t announces £36m AI research funding boost for NHS
NHSX and Accelerated Access Collaborative (AAC) have backed 38 AI-driven research projects
New NICE guidance supports shared decision making
Guideline offers advice on how to engage people who are accessing care in the shared decision-making process
Ontozry scores MHRA authorisation for focal-onset seizures
Drug approved to treat adult patients with epilepsy which has not been adequately controlled with at least two anti-epileptic therapies
